PROCEPT BioRobotics Corporation (PRCT)
NASDAQ: PRCT · Real-Time Price · USD
18.62
+0.62 (3.44%)
At close: Jul 31, 2026, 4:00 PM EDT
18.52
-0.10 (-0.54%)
After-hours: Jul 31, 2026, 7:46 PM EDT
PROCEPT BioRobotics Revenue
PROCEPT BioRobotics had revenue of $83.13M in the quarter ending March 31, 2026, with 20.20% growth. This brings the company's revenue in the last twelve months to $322.02M, up 29.26% year-over-year. In the year 2025, PROCEPT BioRobotics had annual revenue of $308.05M with 37.22% growth.
Revenue (ttm)
$322.02M
Revenue Growth
+29.26%
P/S Ratio
3.29
Revenue / Employee
$362,640
Employees
888
Market Cap
1.06B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 308.05M | 83.56M | 37.22% |
| Dec 31, 2024 | 224.50M | 88.31M | 64.84% |
| Dec 31, 2023 | 136.19M | 61.18M | 81.55% |
| Dec 31, 2022 | 75.01M | 40.54M | 117.60% |
| Dec 31, 2021 | 34.47M | 26.76M | 346.72% |
| Dec 31, 2020 | 7.72M | 1.55M | 25.09% |
| Dec 31, 2019 | 6.17M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| QuidelOrtho | 2.66B |
| Integra LifeSciences Holdings | 1.65B |
| CONMED | 1.37B |
| Lumexa Imaging Holdings | 1.03B |
| Tandem Diabetes Care | 1.03B |
| Bioventus | 576.30M |
| Artivion | 458.69M |
| InMode | 374.64M |
PRCT News
- 3 days ago - SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of September 22, 2026 in PROCEPT BIOROBOTICS CORPORATION Lawsuit - PRCT - PRNewsWire
- 5 days ago - Procept BioRobotics assumed with Neutral from Buy at UBS - TheFly
- 5 days ago - Procept BioRobotics assumed with Neutral from Buy at UBS - TheFly
- 6 days ago - PROCEPT BIOROBOTICS CORPORATION (PRCT) INVESTOR ALERT Investors With Large Losses in PROCEPT BioRobotics Corporation Should Contact Bernstein Liebhard LLP To Discuss Their Rights - GlobeNewsWire
- 19 days ago - PROCEPT BioRobotics® to Report Second Quarter 2026 Financial Results on August 4th, 2026 - GlobeNewsWire
- 4 weeks ago - Procept BioRobotics downgraded to Hold from Buy at Truist - TheFly
- 4 weeks ago - PROCEPT BioRobotics Slides: Conference presentation - Filings
- 5 weeks ago - Procept BioRobotics initiated with an Outperform at Evercore ISI - TheFly